PureTech Health plc (PRTC) — Financial statements
Income statement, balance sheet, and cash flow for PureTech Health plc — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 5↓3.5% | 5↑45.0% | 3↑59.3% | 2↓79.1% | 10 | |
| Cost of Revenue | 0.00 | 0.00↓100.0% | 5↓96.8% | 152↑38.0% | 110 | |
| Gross Profit | 5↑270.6% | 1↑178.4% | -2↑98.8% | -137↓36.1% | -100 | |
| Operating Expenses | ||||||
| R&D Expenses | 46↓15.7% | 54↓43.6% | 96↓17.1% | 116↑42.4% | 82 | |
| General & Administrative Expenses | 21↓24.9% | 27↑9.2% | 25↓29.4% | 36↑16.0% | 31 | |
| Selling & Marketing Expenses | 0.00 | 0.00↓100.0% | 23 | 0.00 | 0.00 | |
| SG&A Expenses | 21↓24.9% | 27↓43.2% | 48↑35.6% | 36↑16.0% | 31 | |
| Other Expenses | 37↓37.3% | 59↑165.1% | -90↑0.8% | -91↓289.2% | 48 | |
| Operating Expenses | 103↓26.5% | 140↑157.4% | 55↓10.6% | 61↓61.9% | 160 | |
| Total Costs & Expenses | 103↓26.5% | 140↓6.1% | 150↓29.9% | 213↑27.3% | 168 | |
| Operating Results | ||||||
| Operating Income | -99↑27.6% | -136↑6.9% | -146↑26.1% | -198↓31.6% | -150 | |
| Depreciation & Amortization | 3↓6.2% | 4↓27.6% | 5↓44.5% | 9↑22.9% | 7 | |
| EBITDA | -62↓265.3% | 37↑421.5% | -12↑93.8% | -189↓807.5% | 27 | |
| EBIT | -65↓292.7% | 34↑304.2% | -17↑91.6% | -198↓1116.3% | 19 | |
| Interest & Other Income | ||||||
| Net Interest Income | -33↓359.1% | 13↑400.5% | 3↑36.7% | 2↑141.0% | -5 | |
| Interest Income | 13↓42.4% | 23↑41.6% | 16↑176.1% | 6↑2609.8% | 0.21 | |
| Interest Expense | 46↑356.1% | 10↓25.6% | 13↑241.2% | 4↓16.1% | 5 | |
| Non-Operating Income | -33↑80.4% | -170↓31.1% | -130↓12963800.0% | -0.00↑100.0% | -170 | |
| Other Income / Expenses | -12↓107.8% | 160↑45.2% | 110↑4.8% | 105↑15.0% | 91 | |
| Income Before Tax | -111↓566.6% | 24↑165.9% | -36↑61.1% | -93↓57.4% | -59 | |
| Income Tax Expense | -0.84↑79.0% | -4↓113.1% | 31↑154.8% | -56↓1583.5% | 4 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -110↓496.2% | 28↑141.7% | -67↓79.8% | -37↑40.9% | -63 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -110↓305.1% | 54↑181.4% | -66↓30.5% | -50↑16.8% | -61 | |
| Bottom-Line Net Income | -110↓305.1% | 54↑181.4% | -66↓30.5% | -50↑16.8% | -61 | |
| EPS (Basic) | -46.00↓2400.0% | 2.00↑183.3% | -2.40↓33.3% | -1.80↑14.3% | -2.10 | |
| EPS (Diluted) | -46.00↓2400.0% | 2.00↑183.3% | -2.40↓33.3% | -1.80↑14.3% | -2.10 | |
| Weighted Average Shares | 2↓91.1% | 27↓2.4% | 28↓1.2% | 28↓2.4% | 29 | |
| Weighted Average Diluted Shares | 2↓91.1% | 27↓2.4% | 28↓3.0% | 28↓0.6% | 29 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.